Tilray Brands Inc（TLRY）の株式分析TLRYTilray Brands Inc

Tilray Brands, Inc. is a lifestyle consumer products company, which focuses on providing research-backed medical cannabis products to physicians, pharmacies, and patients around the world. The Company operates in four segments, which include cannabis operations, which encompasses the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. Beverage operations, which encompasses the production, marketing, and sale of beverage products. Distribution operations, which encompasses the purchase and resale of pharmaceutical products to customers, and Wellness products, which encompasses wellness and better-for-you foods and beverages. It offers a portfolio of brands and products across medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods. It also owns digital healthcare and patient engagement platform, focused on medical cannabis education, physician consultations, and patient support services. It operates in the Healthcare sector (MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry).

Tilray Brands Inc is not a good buy right now due to its significant financial challenges and poor technical indicators. The current price is $2.81, and the company has a very low RSI of 11.468, indicating it is oversold. Furthermore, the forward P/E ratio is extremely high at 1000, suggesting that investors are not expecting earnings growth in the near future. The company also reported a net loss of $49.57 million in its latest quarter, which raises concerns about its profitability and cash flow management. The main risk is the declining cannabis revenue, which fell 13% year-over-year, highlighting the volatility and uncertainty surrounding its core business.

3 analysts cover TLRY: 3 rate it Buy, 0 Hold and 0 Sell. The average price target is 9.57.